Dimethaid

DMX-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about DMX-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
September 15, 2005
New management. Doesn't follow this company actively because it doesn't have much in the way of earnings. In the bottom 10% of his database.
Dimethaid (DMX-T)
September 15, 2005
New management. Doesn't follow this company actively because it doesn't have much in the way of earnings. In the bottom 10% of his database.
Robert McWhirter
President, Selective Asset Management
Price
$0.185
Owned
No
DON'T BUY
DON'T BUY
January 25, 2005
Very much news driven. Speculative. Need a very strong stomach.
Dimethaid (DMX-T)
January 25, 2005
Very much news driven. Speculative. Need a very strong stomach.
David Baskin
President, Baskin Wealth Management
Price
$0.400
Owned
No
DON'T BUY
DON'T BUY
November 27, 2003
Looked like it was going to break out of a 200-day moving average but fell back. Did a special warrant financing in October for sales/marketing of Pennsaid. FDA approval has been pending for a long time. Caution.
Dimethaid (DMX-T)
November 27, 2003
Looked like it was going to break out of a 200-day moving average but fell back. Did a special warrant financing in October for sales/marketing of Pennsaid. FDA approval has been pending for a long time. Caution.
Lou Schizas
Business Editor, Market Call
Price
$1.330
Owned
Unknown
DON'T BUY
DON'T BUY
July 3, 2003
Has been losing value for some time. Need to have a lot of faith. They are still waiting for a green light from the FDA. The big risk is their inability to move sales.
Dimethaid (DMX-T)
July 3, 2003
Has been losing value for some time. Need to have a lot of faith. They are still waiting for a green light from the FDA. The big risk is their inability to move sales.
Lou Schizas
Business Editor, Market Call
Price
$1.740
Owned
Unknown
BUY
BUY
March 27, 2003
A this point, its a reasonable bet.
Dimethaid (DMX-T)
March 27, 2003
A this point, its a reasonable bet.
Robert Floyd
President, R A Floyd Management
Price
$2.090
Owned
Unknown
BUY
BUY
March 19, 2001
Approaching commercialization.
Dimethaid (DMX-T)
March 19, 2001
Approaching commercialization.
Ed Ho
Portfolio Manager, Dynamic Mutual Funds
Price
$7.250
Owned
Unknown
WATCH
WATCH
January 2, 2001
Attractive, but wait for partnership deal with Johnson & Johnson
Dimethaid (DMX-T)
January 2, 2001
Attractive, but wait for partnership deal with Johnson & Johnson
Steven Misener
Portfolio Manager, C.I. Mutual Funds
Price
$8.100
Owned
Unknown
BUY
BUY
November 29, 2000
Not a big enough following but should be OK
Dimethaid (DMX-T)
November 29, 2000
Not a big enough following but should be OK
Pier Donnini
Head of Institutional Securities, Yorkton Securities
Price
$5.600
Owned
Unknown
BUY
BUY
October 13, 2000
Good techs. Have to convince the Feds its a good way to deliver pain relief
Dimethaid (DMX-T)
October 13, 2000
Good techs. Have to convince the Feds its a good way to deliver pain relief
Glenn Paradis, BA, CFA
Vice President & Sr Portfolio Manager, Equities, Aegon Capital Management Inc.
Price
$5.000
Owned
Unknown
Showing 1 to 9 of 9 entries
  • «
  • 1
  • »